本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Sarepta Therapeutics

97.19
-1.1800-1.20%
盤後97.190.00000.00%19:44 EDT
成交量:87.42萬
成交額:8,558.53萬
市值:94.31億
市盈率:41.57
高:100.00
開:99.00
低:97.06
收:98.37
資料載入中...
2024/06/24

關聯方擬減持公告

Form144|賽普拉高管Bilal Arif擬減持7859股,總價約126萬美元
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals